Andriescu L, Buiuc A I, Dolinescu C, Dragomir C, Albulescu E
Facultatea de Medicină, Clinica a III-a Chirurgie, Universitatea de Medicina şi Farmacie Gr.T. Popa, Iaşi.
Rev Med Chir Soc Med Nat Iasi. 2000 Apr-Jun;104(2):103-8.
The aim of the study was to analyze the progression of invasive thymomas associated with myasthenia gravis, after the resection and the progression of unresectable invasive thymomas with a combined chemoradiotherapy. The study was performed on two groups of patients: 8 patients with invasive thymomas and myasthenia gravis operated at the 3rd Surgical Clinic between 1986-1999; 4 patients with unresectable invasive thymomas treated at the Radiology-Oncology Clinic by combined chemoradiotherapy, between 1993-1998. The results are presented for each group of patients, separately.
The best treatment of invasive thymomas is the multimodal one. The timing of each method was established based on the collaboration between surgeons, medical oncologists, radiotherapists and neurologists, depending on the characteristics of each patient.
本研究的目的是分析重症肌无力相关侵袭性胸腺瘤切除术后的进展情况，以及不可切除的侵袭性胸腺瘤联合放化疗后的进展情况。该研究针对两组患者进行：1986年至1999年期间在第三外科诊所接受手术的8例侵袭性胸腺瘤合并重症肌无力患者；1993年至1998年期间在放射肿瘤诊所接受联合放化疗的4例不可切除的侵袭性胸腺瘤患者。结果分别针对每组患者呈现。
侵袭性胸腺瘤的最佳治疗方法是多模式治疗。每种方法的时机是根据外科医生、医学肿瘤学家、放射治疗师和神经科医生之间的合作确定的，具体取决于每位患者的特征。
Zotero 插件